Status:

RECRUITING

Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

MedStar National Rehabilitation Network

The Methodist Hospital Research Institute

Conditions:

Spinal Cord Injuries

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The purpose of this study is to determine if electric stimulation to the leg, called transcutaneous tibial nerve stimulation (TTNS), can improve bladder outcomes in acute spinal cord injury.

Detailed Description

The purpose of this study is to see how well TTNS works at preventing incontinence in people with paraplegia from SCI that perform intermittent catheterization to empty their bladder. This study will ...

Eligibility Criteria

Inclusion

  • 18-75 years old
  • Traumatic or non-traumatic SCI
  • Admitted to inpatient rehabilitation within 6 weeks
  • T9 level of injury and above who are at greatest risk of morbid NGB
  • Regionally located to allow follow-up
  • English or Spanish speaking

Exclusion

  • History of genitourinary diagnoses (i.e. prostate hypertrophy, overactive bladder, cancer, etc.)
  • History of central nervous system disorder (i.e. prior SCI, stroke, brain injury, Parkinson's disease, MS, etc.)
  • History of peripheral neuropathy
  • pre-SCI symptoms of peripheral neuropathy (numbness and/or tingling in feet, sharp/jabbing/burning pain in feet, sensitivity to touch, lack of coordination, muscle weakness, etc.)
  • Pregnancy
  • Known injury to the lumbosacral spinal cord or plexus, or pelvis with associated neuropathy
  • concern for tibial nerve pathway injury
  • absence of toe flexion or autonomic dysreflexia during electric stimulation test
  • Potential for progressive SCI including neurodegenerative SCI, ALS, cancer myelopathy, Multiple sclerosis, transverse myelitis

Key Trial Info

Start Date :

June 8 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04350359

Start Date

June 8 2020

End Date

July 1 2026

Last Update

July 14 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

MedStar National Rehabilitation Hospital

Washington D.C., District of Columbia, United States, 20010

2

TIRR Memorial Hermann Research Center

Houston, Texas, United States, 77030